Further investigation is necessary to establish if elevated galectin-3 plasma concentration is a useful biomarker for screening young individuals with ventricular arrhythmia who are at risk of structural cardiovascular system pathology. This evidence concerns the gene LGALS3 and Ventricular arrhythmia.